Synthetic organic

CCR5 antagonist 34.

CCR5 antagonist 34.

CCT129957.

CCT129957.

InformationCCT196969 is a novel orally available, pan-RAFinhibitor with anti-SRCactivity. It also inhibits SRC, LCK, and the p38 MAPKs.TargetsCRAF (Cell-free assay): LCK (Cell-free assay): Src (Cell-free assay): V600E-BRAF (Cell-free assay): BRAF

InformationCCT196969 is a novel orally available, pan-RAFinhibitor with anti-SRCactivity. It also inhibits SRC, LCK, and the p38 MAPKs.TargetsCRAF (Cell-free assay): LCK (Cell-free assay): Src (Cell-free assay): V600E-BRAF (Cell-free assay): BRAF

InformationCCT196969 is a novel orally available, pan-RAFinhibitor with anti-SRCactivity. It also inhibits SRC, LCK, and the p38 MAPKs.TargetsCRAF (Cell-free assay): LCK (Cell-free assay): Src (Cell-free assay): V600E-BRAF (Cell-free assay): BRAF

InformationCCT196969 is a novel orally available, pan-RAFinhibitor with anti-SRCactivity. It also inhibits SRC, LCK, and the p38 MAPKs.TargetsCRAF (Cell-free assay): LCK (Cell-free assay): Src (Cell-free assay): V600E-BRAF (Cell-free assay): BRAF

InformationCCT196969 is a novel orally available, pan-RAFinhibitor with anti-SRCactivity. It also inhibits SRC, LCK, and the p38 MAPKs.TargetsCRAF (Cell-free assay): LCK (Cell-free assay): Src (Cell-free assay): V600E-BRAF (Cell-free assay): BRAF

CCT241161.

CCT241161.

CCT241533.